The Telehealth Economy
The platforms, the pharmacies, and the policy that shape how patients actually access these drugs.
Telehealth is now the front door for tens of millions of prescriptions. This desk follows the business models, the FDA enforcement, the insurance picture, and the policy arc that will shape who can access these medications in the next five years — and under what terms.
This Week's Feature
Hand-picked by the desk.
The Telehealth Boom Was Built on a Drug Shortage. What Now?
Ro, Hims, Found, Mochi — the platforms grew by arbitraging a specific FDA exemption on compounded semaglutide. That window is closing. The playbook that follows will define the next five years of the industry.
Read the feature →